Targeting Cognition in PTSD: Pregnenolone Augmentation of SSRIs

Completed · Not applicable · Has a placebo group

Conditions studied: Stress Disorders, Post-Traumatic

In brief

This study will test the therapeutic potential of augmenting a stable SSRI regimen with the neurosteroid pregnenolone to reduce cognitive symptoms and PTSD symptoms in patients diagnosed with PTSD.

Key facts

Study ID
NCT00560781
Run by
Durham VA Medical Center
People needed
27
Starts
2006-04-01
Expected to finish
2007-05-01
Last updated by the study team
2014-02-26

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.